Trimetazidine Alleviates Postresuscitation Myocardial Dysfunction and Improves 96-Hour Survival in a Ventricular Fibrillation Rat Model.

Li, Jingru; Qi, Yuantong; Wang, Jianjie; Dai, Chenxi; Chen, Bihua; Li, Yongqin

Li, Jingru; Qi, Yuantong; Wang, Jianjie; Dai, Chenxi; Chen, Bihua; Li, Yongqin.

Afiliação

Li J; Department of Biomedical Engineering and Imaging Medicine Army Medical University Chongqing China.
Qi Y; Department of Pharmaceutics College of Pharmacy Army Medical University Chongqing China.
Wang J; Department of Biomedical Engineering and Imaging Medicine Army Medical University Chongqing China.
Dai C; Department of Biomedical Engineering and Imaging Medicine Army Medical University Chongqing China.
Chen B; Department of Biomedical Engineering and Imaging Medicine Army Medical University Chongqing China.
Li Y; Department of Biomedical Engineering and Imaging Medicine Army Medical University Chongqing China.

J Am Heart Assoc ; 11(6): e023378, 2022 03 15.

Article em En | MEDLINE | ID: mdl-35261264

Assuntos

Cardiomiopatias; Reanimação Cardiopulmonar; Trimetazidina; Animais; Ratos; Biomarcadores; Reanimação Cardiopulmonar/métodos; Inflamação; Ratos Sprague-Dawley; Volume Sistólico; Trimetazidina/farmacologia; Trimetazidina/uso terapêutico; Fibrilação Ventricular/etiologia; Fibrilação Ventricular/prevenção & controle; Função Ventricular Esquerda

Palavras-chave

cardiac arrest; cardiopulmonary resuscitation; myocardial dysfunction; oxidative stress; targeted temperature management; trimetazidine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Trimetazidina / Reanimação Cardiopulmonar / Cardiomiopatias Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Revista: J Am Heart Assoc Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google